BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27682648)

  • 21. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.
    Hammerstingl R; Huppertz A; Breuer J; Balzer T; Blakeborough A; Carter R; Fusté LC; Heinz-Peer G; Judmaier W; Laniado M; Manfredi RM; Mathieu DG; Müller D; Mortelè K; Reimer P; Reiser MF; Robinson PJ; Shamsi K; Strotzer M; Taupitz M; Tombach B; Valeri G; van Beers BE; Vogl TJ;
    Eur Radiol; 2008 Mar; 18(3):457-67. PubMed ID: 18058107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
    Zech CJ; Justo N; Lang A; Ba-Ssalamah A; Kim MJ; Rinde H; Jonas E
    Eur Radiol; 2016 Nov; 26(11):4121-4130. PubMed ID: 26905871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
    Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?
    Maiwald B; Lobsien D; Kahn T; Stumpp P
    PLoS One; 2014; 9(11):e111935. PubMed ID: 25375778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT.
    Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T
    Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
    J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases.
    Zech CJ; Korpraphong P; Huppertz A; Denecke T; Kim MJ; Tanomkiat W; Jonas E; Ba-Ssalamah A;
    Br J Surg; 2014 May; 101(6):613-21. PubMed ID: 24652690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
    Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
    Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases.
    Chen L; Zhang J; Zhang L; Bao J; Liu C; Xia Y; Huang X; Wang J
    PLoS One; 2012; 7(11):e48681. PubMed ID: 23144927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours.
    Schreiter NF; Nogami M; Steffen I; Pape UF; Hamm B; Brenner W; Röttgen R
    Eur Radiol; 2012 Feb; 22(2):458-67. PubMed ID: 21904802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.
    Akai H; Kiryu S; Matsuda I; Satou J; Takao H; Tajima T; Watanabe Y; Imamura H; Kokudo N; Akahane M; Ohtomo K
    Eur J Radiol; 2011 Nov; 80(2):310-5. PubMed ID: 20732773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK; Kim CS; Han YM; Lee YH
    Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer?
    Kang SI; Kim DW; Cho JY; Park J; Lee KH; Son IT; Oh HK; Kang SB
    Dis Colon Rectum; 2017 Sep; 60(9):936-944. PubMed ID: 28796732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis.
    Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Matsueda K; Saiura A
    Ann Surg; 2015 Dec; 262(6):1086-91. PubMed ID: 26010441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).
    Kim YK; Lee MW; Lee WJ; Kim SH; Rhim H; Lim JH; Choi D; Kim YS; Jang KM; Lee SJ; Lim HK
    Invest Radiol; 2012 Mar; 47(3):159-66. PubMed ID: 22330426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT.
    Kim YK; Park G; Kim CS; Yu HC; Han YM
    Br J Radiol; 2012 May; 85(1013):539-47. PubMed ID: 22556405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis.
    Choi SH; Kim SY; Park SH; Kim KW; Lee JY; Lee SS; Lee MG
    J Magn Reson Imaging; 2018 May; 47(5):1237-1250. PubMed ID: 28901685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.